Suppr超能文献

血清可溶性细胞间黏附分子-1(sICAM-1):重度寻常痤疮中一种新型潜在生物标志物。

Serum Soluble Intercellular Adhesion Molecule-1 (sICAM-1): A Novel Potential Biomarker in Severe Acne Vulgaris.

作者信息

Mustafa Amany Ibrahim, Ebrahim Adel Ali, Abel Halim Waleed Abdel Lateef, Fawzy Eman, Abdou Ahmed Fathy

机构信息

Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Benha University, Egypt.

Department of Clinical and Chemical Pathology, Faculty of Medicine, Benha University, Egypt.

出版信息

Indian J Dermatol. 2022 Sep-Oct;67(5):512-517. doi: 10.4103/ijd.ijd_387_21.

Abstract

BACKGROUND

Acne vulgaris (AV) is a chronic inflammatory disorder. Intercellular adhesion molecule-1 (ICAM-1) is a vital adhesion molecule mediating cellular adhesion during the inflammatory process.

AIMS AND OBJECTIVES

To evaluate serum soluble intercellular adhesion molecule-1 (sICAM-1) level in AV patients as an attempt to elucidate its role in acne pathogenesis and to relate with studied clinical parameters.

MATERIALS AND METHODS

Serum sICAM-1 level was measured using ELISA technique in 60 patients and 60 controls.

RESULTS

Serum sICAM-1 level was significantly elevated in studied patients than controls ( < 0.001). Additionally, its level increased significantly with increased acne severity ( < 0.001) but not in patients with post acne scars ( > 0.05).

CONCLUSION

Serum sICAM-1 could be a marker for acne etiopathogenesis. Furthermore, it might be considered as a predictor for disease severity.

摘要

背景

寻常痤疮(AV)是一种慢性炎症性疾病。细胞间黏附分子-1(ICAM-1)是一种在炎症过程中介导细胞黏附的重要黏附分子。

目的

评估寻常痤疮患者血清可溶性细胞间黏附分子-1(sICAM-1)水平,以阐明其在痤疮发病机制中的作用,并与所研究的临床参数相关联。

材料与方法

采用酶联免疫吸附测定(ELISA)技术检测60例患者和60例对照者的血清sICAM-1水平。

结果

研究患者的血清sICAM-1水平显著高于对照组(<0.001)。此外,其水平随痤疮严重程度的增加而显著升高(<0.001),但痤疮后瘢痕患者的水平无显著变化(>0.05)。

结论

血清sICAM-1可能是痤疮病因发病机制的一个标志物。此外,它可能被视为疾病严重程度的一个预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7eef/9971765/514c198b4fed/IJD-67-512-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验